Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles

Completed

Conditions studied: Cancer

In brief

The purpose of this study is to examine doctor-patient communication about treatment options which may include an experimental, new treatment for cancer. What we learn from this study may help us to teach doctors better ways to talk to their patients.

Key facts

Study ID

NCT00582192

Run by

Memorial Sloan Kettering Cancer Center

People needed

17

Starts

2007-07-01

Expected to finish

2009-04-01

Last updated by the study team

2009-05-01

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients at the outpatient oncology clinics of the six participating physicians (Drs Schwartz, Scher, Slovin, Tse, Shah \& Carvajal)
• Diagnosed with cancer
• Eligible for a Phase I trial
• Discussing participation in such a trial with their physician during their visit

You may not qualify if…

• Fewer than 18 years of age
• Not proficient in English
• Cognitively or physically impaired, rendering them incapable of providing informed consent to participate in the study

Where it is running

• Memorial Sloan-Kettering Cancer Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.